Re: When is Q1 ER? TIA, eom.
yeah, quite a down-draft in both the biotech and tech sector recently and even worse for both SGMO and VHC... I'm glad I took quite a bit of profit on the way up in those two and moved into high yield bond & preferred stock funds which have done well... and on the way down, i added shares (too early) in both SGMO and VHC at an avg of ~ $17 each.
company specific:
SGMO did a $100M secondary on 3/20 at $22.50... do you think DNDN could raise $100M in a secondary at any price, much less over $2.00 ?
and yeah, VHC has gone from a high of $40 down to $13 over the last two years... it's curious you picked 2 years... when Johnson was hired 2 years ago, DNDN was at $13.58... today it's $2.69.
i dunno what your point is but you're your own worst enemy